These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38212892)

  • 1. N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
    Gerber TS; Ridder DA; Goeppert B; Brobeil A; Stenzel P; Zimmer S; Jäkel J; Metzig MO; Schwab R; Martin SZ; Kiss A; Bergmann F; Schirmacher P; Galle PR; Lang H; Roth W; Straub BK
    Int J Cancer; 2024 May; 154(10):1857-1868. PubMed ID: 38212892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.
    Akita M; Sawada R; Komatsu M; Suleman N; Itoh T; Ajiki T; Heaton N; Fukumoto T; Zen Y
    Hum Pathol; 2021 Mar; 109():45-52. PubMed ID: 33321161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.
    Mosnier JF; Kandel C; Cazals-Hatem D; Bou-Hanna C; Gournay J; Jarry A; Laboisse CL
    Mod Pathol; 2009 Feb; 22(2):182-90. PubMed ID: 18622386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver.
    Kozyraki R; Scoazec JY; Flejou JF; D'Errico A; Bedossa P; Terris B; Fiorentino M; Bringuier AF; Grigioni WF; Feldmann G
    Gastroenterology; 1996 Apr; 110(4):1137-49. PubMed ID: 8613003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas.
    Gerber TS; Goeppert B; Hausen A; Witzel HR; Bartsch F; Schindeldecker M; Gröger LK; Ridder DA; Cahyadi O; Esposito I; Gaida MM; Schirmacher P; Galle PR; Lang H; Roth W; Straub BK
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
    Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNF-1β is a More Sensitive and Specific Marker Than C-Reactive Protein for Identifying Biliary Differentiation in Primary Hepatic Carcinomas.
    Patil PA; Taddei T; Jain D; Zhang X
    Arch Pathol Lab Med; 2022 Jan; 146(2):220-226. PubMed ID: 34086854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.
    Wang C; Chen C; Hu W; Tao L; Chen J
    Apoptosis; 2024 Apr; 29(3-4):460-481. PubMed ID: 38017206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms.
    Mounajjed T; Zhang L; Wu TT
    Hum Pathol; 2013 Apr; 44(4):542-50. PubMed ID: 23079207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors.
    Gerber TS; Ridder DA; Schindeldecker M; Weinmann A; Duret D; Breuhahn K; Galle PR; Schirmacher P; Roth W; Lang H; Straub BK
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC determines lineage commitment in KRAS-driven primary liver cancer development.
    D'Artista L; Moschopoulou AA; Barozzi I; Craig AJ; Seehawer M; Herrmann L; Minnich M; Kang TW; Rist E; Henning M; Klotz S; Heinzmann F; Harbig J; Sipos B; Longerich T; Eilers M; Dauch D; Zuber J; Wang XW; Zender L
    J Hepatol; 2023 Jul; 79(1):141-149. PubMed ID: 36906109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Pomyen Y; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Sripan D; Chornkrathok C; Budhu A; Budhisawasdi V; Lertprasertsuke N; Chotirosniramit A; Pairojkul C; Auewarakul CU; Ungtrakul T; Sricharunrat T; Phornphutkul K; Sangrajang S; Loffredo CA; Harris CC; Mahidol C; Wang XW; Ruchirawat M;
    Sci Rep; 2023 Jul; 13(1):11406. PubMed ID: 37452065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin.
    Asayama Y; Taguchi Ki K; Aishima Si S; Nishi H; Masuda K; Tsuneyoshi M
    Liver; 2002 Feb; 22(1):43-50. PubMed ID: 11906618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray.
    Nitta T; Mitsuhashi T; Hatanaka Y; Miyamoto M; Oba K; Tsuchikawa T; Suzuki Y; Hatanaka KC; Hirano S; Matsuno Y
    Br J Cancer; 2014 Sep; 111(7):1363-72. PubMed ID: 25077440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing.
    Craig AJ; Silveira MAD; Ma L; Revsine M; Wang L; Heinrich S; Rae Z; Ruchinskas A; Dadkhah K; Do W; Behrens S; Mehrabadi FR; Dominguez DA; Forgues M; Budhu A; Chaisaingmongkol J; Hernandez JM; Davis JL; Tran B; Marquardt JU; Ruchirawat M; Kelly M; Greten TF; Wang XW
    Cell Rep; 2023 Nov; 42(11):113446. PubMed ID: 37980571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Acylphosphatase 1 Expression in Combined HCC-iCCA, HCC, and iCCA.
    Sakano Y; Noda T; Kobayashi S; Kitagawa A; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Gotoh K; Asaoka T; Tanemura M; Umeshita K; Mimori K; Doki Y; Eguchi H
    Dig Dis Sci; 2022 Aug; 67(8):3817-3830. PubMed ID: 34626299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD73 expression in normal and pathological human hepatobiliopancreatic tissues.
    Sciarra A; Monteiro I; Ménétrier-Caux C; Caux C; Gilbert B; Halkic N; La Rosa S; Romero P; Sempoux C; de Leval L
    Cancer Immunol Immunother; 2019 Mar; 68(3):467-478. PubMed ID: 30607549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor ratio of unsaturated to saturated sulfatide species is associated with disease-free survival in intrahepatic cholangiocarcinoma.
    Huizing L; Chen L; Roeth AA; Heij LR; Flinders B; Bouwense SAW; Balluff B; Neumann UP; Heeren RMA; Olde Damink SWM; Vreeken RJ; Schaap FG
    Cell Oncol (Dordr); 2023 Jun; 46(3):629-642. PubMed ID: 36630049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Analysis in the Categorization of Poorly Differentiated Primary Liver Carcinomas.
    Kikuchi AT; Umetsu S; Joseph N; Kakar S
    Am J Surg Pathol; 2023 Nov; 47(11):1207-1218. PubMed ID: 37661782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.